GlassScriptPhysician profile
Nancy H Tran
NPI 1457393209
$1,453.53
in general payments reported to CMS, 2019-2025
18 companies · $1,214 in 2025
The $1,214 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.29 · 2020: $15.02 · 2022: $40.78 · 2024: $145 · 2025: $1,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,217 · Travel and Lodging: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,217.30 |
| Travel and Lodging | $142.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $312.68 | 2024-2025 | |
| Corcept Therapeutics | $178.04 | 2025 | Korlym |
| E.R. Squibb & Sons, L.L.C. | $142.14 | 2025 | |
| Abbvie INC. | $99.33 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $85.43 | 2020-2025 | Farxiga |
| Teva Pharmaceuticals USA, INC. | $78.24 | 2025 | Austedo Xr |
| Lundbeck LLC | $76.61 | 2025 | Rexulti, Vyepti |
| Merck Sharp & Dohme LLC | $66.69 | 2025 | Verquvo |
| Verona Pharma, INC. | $65.42 | 2025 | Ohtuvayre |
| Otsuka America Pharmaceutical, INC. | $62.02 | 2019-2022 | |
| Daiichi Sankyo INC. | $57.80 | 2025 | Injectafer |
| Lilly USA, LLC | $56.62 | 2025 | Jardiance, Kisunla, Zepbound |
| Harmony Biosciences LLC | $50.21 | 2025 | |
| Phathom Pharmaceuticals, INC. | $38.57 | 2025 | Voquezna |
| Axsome Therapeutics, INC. | $33.17 | 2025 | Auvelity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.76 | 2025 | Ofev |
| Fresenius USA Marketing, INC. | $17.05 | 2019 | |
| Exact Sciences Corporation | $14.75 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.